Feb 17 (Reuters) - Vaxil Bio Ltd VXL.V :
* VAXIL PROVIDES STRATEGY UPDATE FROM CONCLUSION OF COVID-19 CHALLENGE STUDY
* VAXIL BIO - USAMRIID COVID-19 MOUSE MODEL CHALLENGE EXPERIMENT DEMONSTRATED THAT CO'S SP-BASED VACCINE CANDIDATE GENERATED SPECIFIC IMMUNE RESPONSE
* VAXIL BIO - WILL EVALUATE ALTERNATE PEPTIDE DELIVERY APPROACHES, INCLUDING ORAL ADMINISTRATION
* VAXIL BIO LTD - IMMUNE RESPONSE GENERATED BY VACCINE CANDIDATE WAS NOT ACCOMPANIED BY VACCINE PROTECTION OF ANIMALS